VHCP Management III, LLC

Q4 2019 13F Holdings

  • Location
    new york, NY
  • Num holdings

    18

  • Value ($000)

    $503,631

  • Date Filed
    02/13/2020
  • Form type
    13F-HR
  • CIK
    0001738053
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2019 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
AXSM
AXSM

Axsome Therapeutics Inc

COM
05464T104
$160.00M
32 %

1,547,994

CNST
CNST

Constellation Pharmaceuticals

COM
210373106
$118.54M
24 %

2,516,242

MIST
MIST

Milestone Pharmaceuticals Inc

COM
59935V107
$33.09M
7 %

2,066,529

RLMD
RLMD

Relmada Therapeutics Inc

COM
75955J402
$29.95M
6 %

767,938

ETNB
ETNB

89Bio Inc

COM
282559103
$25.21M
5 %

958,765

TXG
TXG

10X Genomics Inc.

COM
88025U109
$22.88M
5 %

300,000

FTSV
FTSV

Forty Seven Inc

COM
34983P104
$20.33M
4 %

516,381

ITCI
ITCI

Intra-Cellular Therapies Inc

COM
46116X101
$19.73M
4 %

575,000

ISEE
ISEE

Iveric Bio Inc

COM
46583P102
$14.58M
3 %

1,699,797

KALV
KALV

Kalvista Pharmaceuticals

COM
483497103
$11.04M
2 %

619,905

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 18